FDA approves new melanoma drug from Bristol-Myers
WASHINGTON - The Food and Drug Administration has approved a new drug from Bristol-Myers Squibb to treat the deadliest form of skin cancer.
The agency approved Opdivo for patients with hard-to-treat melanoma that cannot be removed through surgery or has spread throughout the body. The approval was based on preliminary studies showing the drug helped shrink tumors in some patients.
About 76,100 people in the U.S. will be diagnosed with melanoma this year and 9,710 people are expected to die from the disease.
Melanoma long has been considered one of the toughest cancers to treat, with few drug options up until a few years ago. Since 2011, the FDA has approved seven new drugs for the skin cancer, including Opdivo.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Friday 9-21 afternoon weather
Father arrested for using toddler to steal prizes from claw machine
Get ready: The Ascesnion Hot Air Balloon Festival has returned
LSU's historic Long Fieldhouse gets money for renovation work
Environmentalists and West Baton Rouge Parish residents fill parish council chamber against...